Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The Oakmark Global Select Fund underperformed the MSCI World Index in Q4 2025. Key activity included establishing a new position in Sanofi and completely exiting Mercedes-Benz and Roche, while Bayer and Alibaba acted as the quarter's primary driver and detractor, respectively.
Full Quick Take
The Oakmark Global Select Fund underperformed the MSCI World Index in Q4 2025. Key activity included establishing a new position in Sanofi and completely exiting Mercedes-Benz and Roche, while Bayer and Alibaba acted as the quarter's primary driver and detractor, respectively.
Miller/Howard's energy fund outperformed despite sector weakness by defensively repositioning toward natural gas pipelines benefiting from AI/data center demand. Chinese oil demand disappointment drove sector weakness, but potential fiscal stimulus could reignite consumption.
Full Quick Take
Miller/Howard's energy fund outperformed despite sector weakness by defensively repositioning toward natural gas pipelines benefiting from AI/data center demand. Chinese oil demand disappointment drove sector weakness, but potential fiscal stimulus could reignite consumption.
ClearBridge's dividend strategy captured 85% of Q4 gains while positioning for 2024 with increased exposure to oversold pipelines, utilities, and real estate. The team reduced high-multiple growth stocks and added defensive healthcare names.
Full Quick Take
ClearBridge's dividend strategy captured 85% of Q4 gains while positioning for 2024 with increased exposure to oversold pipelines, utilities, and real estate. The team reduced high-multiple growth stocks and added defensive healthcare names.